IUHSA
TEVA icon

Itau Unibanco Holding S.A.’s Teva Pharmaceuticals TEVA Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,000
Closed -$453K – 441
2025
Q2 		$453K Buy
+27,000
New +$436K 0.02% 157
2019
Q4 		– Sell
-11,405
Closed -$105K – 973
2019
Q3 		$105K Hold
11,405
– – 0.01% 206
2019
Q2 		$105K Sell
11,405
-6,641
-37% -$80.1K 0.01% 532
2019
Q1 		$274K Hold
18,046
– – 0.01% 161
2018
Q4 		$274K Buy
18,046
+38
+0.2% +$779 0.01% 161
2018
Q3 		$388K Buy
18,008
+7,167
+66% +$166K 0.02% 147
2018
Q2 		$263K Sell
10,841
-586
-5% -$11.9K 0.03% 230
2018
Q1 		$195K Buy
11,427
+7,531
+193% +$147K ﹤0.01% 381
2017
Q4 		$74K Buy
3,896
+1,231
+46% +$18.5K ﹤0.01% 394
2017
Q3 		$149K Buy
2,665
+653
+32% +$14.7K 0.01% 484
2017
Q2 		$67K Buy
2,012
+1,813
+911% +$56.1K 0.01% 265
2017
Q1 		$6K Buy
+199
New +$6.79K ﹤0.01% 624

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PC
PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Itau Unibanco Holding S.A.'s TEVA Position: Q3 2025 in Review

Itau Unibanco Holding S.A. sold out of Teva Pharmaceuticals (TEVA) in Q3 2025, closing a stake of 27,000 shares — an estimated $453K sold.

Itau Unibanco Holding S.A. first reported a position in TEVA in Q1 2017 and held it in 12 quarters. The position peaked at $453K in Q2 2025. 550 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Itau Unibanco Holding S.A. reported no remaining Teva Pharmaceuticals position as of Q3 2025 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 27,000 Teva Pharmaceuticals shares in Q3 2025, an estimated $453K.
  • Itau Unibanco Holding S.A. first reported a position in Teva Pharmaceuticals in Q1 2017 and held it in 12 quarters.
  • Itau Unibanco Holding S.A.'s Teva Pharmaceuticals position peaked at $453K in Q2 2025.
  • 550 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2025.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2025, filed 12 Nov 2025.